CIBA/CHIRON AREDIA PREVENTS SKELETAL MORBIDITY OF MULTIPLE MYELOMA, FDA ADVISORY CMTE. CONCLUDES; OPTIMAL DOSE, DURATION OF THERAPY NEED PHASE IV STUDIES
Executive Summary
Ciba/Chiron's Aredia (pamidronate disodium for injection) prevents bone metastases associated with multiple myeloma, FDA's Oncologic Drugs Advisory Committee agreed unanimously at its July 24 meeting.